AMPHENOL CORP /DE/ (APH) › Cash & EquivalentsAMPHENOL CORP /DE/ (APH) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $74.14M2007: $183.64M2008: $214.99M2009: $384.61M2010: $525.89M2011: $515.10M2012: $690.80M2013: $886.80M2014: $968.90M2015: $1.74B2016: $1.03B2017: $1.72B2018: $1.28B2019: $891.20M2020: $1.70B2021: $1.20B2022: $1.37B2023: $1.48B2024: $3.32B2025: $11.13B$11.13B2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$11.13B+235.6%2024$3.32B+124.9%2023$1.48B+7.4%2022$1.37B+14.7%2021$1.20B-29.7%2020$1.70B+91.0%2019$891.20M-30.3%2018$1.28B-25.6%2017$1.72B+66.2%2016$1.03B-40.4%2015$1.74B+79.3%2014$968.90M+9.3%2013$886.80M+28.4%2012$690.80M+34.1%2011$515.10M-2.1%2010$525.89M+36.7%2009$384.61M+78.9%2008$214.99M+17.1%2007$183.64M+147.7%2006$74.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share